2012, Volume 14, Issue 8
Strategic Study of CAE >> 2012, Volume 14, Issue 8
Boron neutron capture therapy for glioblastoma of prospects and confused
Neurosurgery and Brain & Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
Next Previous
Abstract
Boron neutron capture therapy (BNCT) is a selective radiotherapy of damage tumor cells, and α particle produced by which is effective to prevent glioblastoma multiform recurrence. Clinical trails of BNCT were carried out in fifties to sixties of 20 century in developed countries, but it was limited because of the development of boron carrier and neutron source. This is a review of BNCT prospect on glioblastoma multiform.
References
[ 1 ] Yamamoto T, Nakai K, Matsumura A. Boron neutron capture therapy for glioblastoma [J]. Cancer Lett, 2008, 262 (2) : 143-152 link1
[ 2 ] Cumberlin RL. Clinical research in neutron capture therapy [J].Int J Radiat Oncol Biol Phys, 2002,54(4):992-998.
[ 3 ] Miyatake S, Kawabata S, Yokoyama K, et al. Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas[J].Neurooncol,2009,91 (2):199 -206. link1
[ 4 ] Kageji T, Mizobuchi Y, Nagahiro S, et al. Clinical results of boron neutron capture therapy (BNCT) for glioblastoma [J]. Appl Radiat Isot, 2011,69 (12):1823-1825. link1
[ 5 ] Skold K, Gorlia T, Pellettieri L, et al. Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assess-ment of clinical potential[J]. Br J Radiol,2010,83 (991) :596-603. link1
[ 6 ] Yamamoto T, Matsumura A, Nakai K, et al. Current clinical results of the Tsukuba BNCT trial [J]. Appl Radiat Isot, 2004,61(5):1089-1093. link1
[ 7 ] Aiyama H, Nakai K, Yamamoto T, et al. A clinical trial protocol for second line treatment of malignant brain tumors with BNCT at University of Tsukuba[J]. Appl Radiat Isol, 2011 ,69 (12) :1819-1822. link1
[ 8 ] Barth RF, Coderre JA, Vicente MG, et al. Boron neutron capture therapy of cancer: current status and future prospects [J]. Clin Cancer Res, 2005 ,11 (11) :3987-4002. link1
[ 9 ] Crossley EL, Issa F, Scarf AM, et al. Synthesis and cellular uptake of boron -rich pyrazolopyrimidines: exploitation of the trans-locator protein for the efficient delivery of boron into human glioma cells[J]. Chem Commun (Camb), 2011, 47 (44 ) : 12179-12181. link1
[10] Sumitani S, Oishi M, Yaguchi T, et al. Pharmacokinetics of core-polymerized, boron -conjugated micelles designed for boron neutron capture therapy for cancer [J]. Biomaterials, 2012, 33（13）：3568-3577. link1
[11] Yang W，Barth RF，Wu G，et al.Convection enhanced deliveryof boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors[J].J Neuro-oncology，2009，95：362-365. link1
[12] Yang W，Wu G，Barth RF，et al.Molecular targeting and trealment of composite EGFRvlll and EGFR-positive gliomas using boronated monoclonal antibodies[J].Clinical Cancer Res，2008.14：883-891. link1
[13] 杨伟廉，Barth RF，霍天瑶，等，硼中子俘获疗法进展和展望[J].中华放射肿瘤学杂志，2012，21（1）：76-79. link1
[14] Bao S，Wu Q，Sathornsumetee S，et al.Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor[J].Cancer Res，2006，66（16）：7843-7848 link1
[15] Sun T，Zhou YX，Xie XS，et al.Selective uptake of boronophenylalanine in glioma stem/progenitor cells[J/OL].Applied Radiation and Isotopes（DO1：10.1016/j.apradiso.2012.04.005）. link1
京公网安备 11010502051620号
